Skip to main content
Clinical Trials/CTRI/2025/08/093306
CTRI/2025/08/093306Not yet recruitingNot Applicable

Assessement of dry eye disease in patients of rheumatoid arthritis

Maulana Azad Medical College1 site in 1 country100 target enrollmentStarted: September 10, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
1
Primary Endpoint
To determine the proportion of Dry Eye Disease and ocular surface damage in patients of Rheumatoid arthritis.

Study Overview

Brief Summary

Rheumatoid arthritic is a chronic inflammatory condition. The occurrence of dry eye disease cannot be correlated with the severity of RA, so the evaluation of the DED should be done in all patients of RA regardless of the severity

My study plans to determine the proportion of dry eye disease and ocular surface damage in patients of Rheumatoid arthritis.It also plans to determine the Clinical and laboratory correlates of DED. It also plans to compare which subjective and/or objective test can detect the largest number of RA patient who have dry eye disease.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Adult patients classified as rheumatoid arthritis as per ACR/EULAR 2010 criteria.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

To determine the proportion of Dry Eye Disease and ocular surface damage in patients of Rheumatoid arthritis.

Time Frame: 1 year

Secondary Outcomes

  • 1. To determine the types of DED – aqueous tear deficiency, evaporative dry eye or mixed DED(2. To determine the clinical and laboratory correlates of DED)

Investigators

Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Sumeet Singla

Maulana Azad Medical College

Study Sites (1)

Loading locations...

Similar Trials

Assessement of dry eye disease in patients... | Clinical Trial